Latest Breast Cancer Diagnostics News

Page 2 of 2

BCAL Diagnostics Nears BREASTEST® Launch with Key Milestones and $7M Cash Buffer

BCAL Diagnostics is poised to launch its innovative BREASTEST® breast cancer diagnostic test in early 2025, backed by recent NATA accreditation, patent acceptance, and a $2.6 million R&D tax offset.

Ada Torres

31 Jan 2025

Browse the archive

Full archive

Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026 Jan 2026